ZYME - Zymeworks Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

ZYME is currently covered by 8 analysts with average potential upside of $12.52 (66.3%) backed by 57 price targets and 68 ratings. Documented since 23-May-2017. Analyst's average stock valuation to be materialised ratio is 51.32% with an average time for price targets to be met of 110.44 days.

Most recent stock forecast was given by ROBERT BURNS from HCWAINWRIGHT on 21-Mar-2023.

Highest price target for ZYME is 35, Lowest price target is 5, average price target is 20.

Currently, out of the existing stock ratings of ZYME - 16 which are a Buy (53.33%), 13 which are a Hold (43.33%), 1 which are a Sell (3.33%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

8

$-0.2 (-2.44%)

8

4 days ago

5/12 (41.67%)

$12.12 (72.16%)

49

Buy

12

$3.8 (46.34%)

45

4 days ago

2/7 (28.57%)

$19.41 (123.59%)

373

Hold

9

$0.8 (9.76%)

38

3 months 3 days ago

5/5 (100%)

$0.68 (2.44%)

15

Buy

11

$2.8 (34.15%)

8

3 months 5 days ago

1/3 (33.33%)

$4.29 (36.45%)

5

Buy

8

$-0.2 (-2.44%)

5 months 4 days ago

2/8 (25%)

$8.34 (29.29%)

32

Show more analysts

What is ZYME(Zymeworks Inc) average time for price targets to be met?

On average it took 110.44 days on average for the stock forecasts to be realized with a an average price target met ratio 51.32

Which analyst has the current highest performing score on ZYME(Zymeworks Inc) with a proven track record?

JIM BIRCHENOUGH